Usana Health Sciences (USNA) EBITDA (2010 - 2026)
Usana Health Sciences (USNA) EBITDA from Jul 3, 2010 to Apr 4, 2026. The TTM Usana Health Sciences (USNA) EBITDA is $68M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Usana Health Sciences (USNA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -11.57% |
| 3 Years TTM | -15.96% |
| 5 Years TTM | -18.98% |
| 10 Years TTM | -7.98% |
| All Time TTM | +0.90% |
Annual EBITDA change of Usana Health Sciences (USNA)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $70M | +21.49% |
| 2025 | $58M | -28.75% |
| 2024 | $81M | -23.55% |
| 2023 | $106M | -12.59% |
| 2022 | $121M | -36.39% |
| 2021 | $190M | +48.21% |
| 2020 | $128M | -20.24% |
| 2019 | $161M | -21.57% |
| 2018 | $205M | +38.08% |
| 2017 | $149M | -2.29% |
| 2016 | $152M | +493.91% |
| 2015 | $26M | +31.33% |
| 2014 | $20M | -84.49% |
| 2013 | $126M | +17.52% |
| 2012 | $107M | +24.82% |
| 2011 | $86M | +48.17% |
| 2010 | $58M | N/A |
Comparison Usana Health Sciences (USNA) five years EBITDA CAGR with competitors
Usana Health Sciences (USNA) five years EBITDA CAGR is -18.98%.